Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Johanna Mercier

At a glance: Johanna Mercier is Chief Comm & Corp Aff Officer at Gilead Sciences (GILD). Their latest SEC Form 4, filed Nov 17, 2026, reported a sale of $2.4M. On file: 0 purchase lines ($0) and 27 sale lines ($23.8M).

Disclosed holdings: about $18.5M of GILD stock: 110,684 shares reported on their latest Form 4 (filed Nov 17, 2026), valued at the Nov 19, 2026 close of $167.13. This counts only GILD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Chief Comm & Corp Aff Officer at Gilead Sciences, Inc. (GILD); Chief Commercial Officer at Gilead Sciences, Inc. (GILD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $23.8M

Johanna Mercier's InsiderPrint

27 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Johanna Mercier: 27 trades, 2025 to 20262025: 0 buys, 4 sales2026: 0 buys, 23 sales

Reading this print: Almost only sells, trading about 25 times a year, typically $390K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (27)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. James PursleyPresident · HNGE · 100% match
  2. Robert FauberCEO, President · MCO · 100% match
  3. Timothy HolmeCTO · QS · 100% match
  4. Stefan J. MurryCFO · AAOI · 100% match
  5. Colette KressCFO · NVDA · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 17SEC GILDGilead Sciences, Inc. Sell Plan 13,922124,762 held (−10%) $169.97 $2.4M -1.7%
Nov 17SEC GILDGilead Sciences, Inc. Sell Plan 13,178111,584 held (−11%) $171.09 $2.3M -2.3%
Nov 17SEC GILDGilead Sciences, Inc. Sell Plan 900110,684 held (−1%) $171.69 $155K -2.7%
Oct 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000113,684 held (−3%) $156.22 $469K +7.0%
Sep 16SEC GILDGilead Sciences, Inc. Sell Plan 1,600118,084 held (−1%) $143.69 $230K +16.3%
Sep 16SEC GILDGilead Sciences, Inc. Sell Plan 800117,284 held (−1%) $144.46 $116K +15.7%
Sep 16SEC GILDGilead Sciences, Inc. Sell Plan 600116,684 held (−1%) $145.29 $87K +15.0%
Aug 18SEC GILDGilead Sciences, Inc. Sell Plan 16,530129,704 held (−11%) $137.37 $2.3M +21.7%
Aug 18SEC GILDGilead Sciences, Inc. Sell Plan 11,470118,234 held (−9%) $138.04 $1.6M +21.1%
Jul 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000121,234 held (−2%) $129.92 $390K +28.6%
Jun 16SEC GILDGilead Sciences, Inc. Sell Plan 1,480125,754 held (−1%) $123.42 $183K +35.4%
Jun 16SEC GILDGilead Sciences, Inc. Sell Plan 1,070124,684 held (−1%) $124.00 $133K +34.8%
Jun 16SEC GILDGilead Sciences, Inc. Sell Plan 450124,234 held (−0%) $125.40 $56K +33.3%
May 18SEC GILDGilead Sciences, Inc. Sell Plan 7,749146,030 held (−5%) $130.29 $1.0M +28.3%
May 18SEC GILDGilead Sciences, Inc. Sell Plan 11,177134,853 held (−8%) $131.19 $1.5M +27.4%
May 18SEC GILDGilead Sciences, Inc. Sell Plan 8,374126,479 held (−6%) $132.23 $1.1M +26.4%
May 18SEC GILDGilead Sciences, Inc. Sell Plan 700125,779 held (−1%) $132.75 $93K +25.9%
Apr 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000128,779 held (−2%) $140.96 $423K +18.6%
Mar 17SEC GILDGilead Sciences, Inc. Sell Plan 3,000131,779 held (−2%) $144.23 $433K +15.9%
Feb 18SEC GILDGilead Sciences, Inc. Sell Plan 18,405129,883 held (−12%) $154.18 $2.8M +8.4%
Feb 18SEC GILDGilead Sciences, Inc. Sell Plan 9,395120,488 held (−7%) $154.91 $1.5M +7.9%
Feb 18SEC GILDGilead Sciences, Inc. Sell Plan 200120,288 held (−0%) $155.62 $31K +7.4%
Jan 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000103,221 held (−3%) $124.31 $373K +34.5%
Dec 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000106,221 held (−3%) $122.00 $366K +37.0%
Nov 18SEC GILDGilead Sciences, Inc. Sell Plan 25,524109,669 held (−19%) $125.83 $3.2M +32.8%
Nov 18SEC GILDGilead Sciences, Inc. Sell Plan 2,476107,193 held (−2%) $126.26 $313K +32.4%
Oct 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000110,193 held (−3%) $118.08 $354K +41.5%
  • Sell

    Chief Comm & Corp Aff Officer Johanna Mercier sold $2.4M of GILD at $169.97 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Comm & Corp Aff Officer Johanna Mercier sold $2.3M of GILD at $171.09 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Comm & Corp Aff Officer Johanna Mercier sold $155K of GILD at $171.69 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Comm & Corp Aff Officer Johanna Mercier sold $469K of GILD at $156.22 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Comm & Corp Aff Officer Johanna Mercier sold $230K of GILD at $143.69 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Comm & Corp Aff Officer Johanna Mercier sold $116K of GILD at $144.46 — pre-scheduled 10b5-1 plan sale.

Follow Johanna Mercier

Get one email when Johanna Mercier files a new purchase or sale. Free.

At most one email a day about Johanna Mercier, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.